Clinical Research, Pharma & Healthcare FinancingDelcath Systems Publishes FOCUS Study Analysis on Uveal MelanomaBusiness WireApril 10, 2025April 11, 2025 by Business WireApril 10, 2025April 11, 2025010 Delcath Systems, Inc. (Nasdaq: DCTH), an interventional oncology company focused on the treatment of primary and metastatic liver cancers, today announced the publication of a...
